John Kevin
Teladoc Well being (NYSE:TDOC) is scheduled to announce Q3 financials for 2023 on Tuesday, October 24, after the market shut, whereas its buyers await one other earnings beat from the telehealth supplier.
Buy, New York-headquartered Teladoc (TDOC) has surpassed expectations for quarterly earnings for 2 years in a row, whereas its income has topped forecasts for 4 consecutive quarters. It has overwhelmed quarterly income estimates 88% of the time over the previous two years.
The consensus EPS estimate for the corporate’s third quarter is -$0.37 (+12% Y/Y), and its consensus income estimate stands at $663.1M (+8% Y/Y).
Over the past three months, Wall Avenue has boosted the projections for the corporate’s upcoming earnings thrice, with just one downward revision. Income estimates have seen 11 upward and downward revisions every.
Q3 was a comparatively quiet interval for Teladoc (TDOC). The pandemic-era favourite noticed its inventory greater than double in worth in 2020 as sufferers flocked to telehealth companies amid COVID-driven considerations about social interactions.
Nonetheless, TDOC shares surged in July after the corporate lifted its full-year earnings and income steering to -$1.60 loss per share and $2.6B-$2.675B, from -$1.70-$1.25 and $2.575B-2.675B, respectively.